95%,内毒素<0.1EU/μg,高活性高纯度低内毒素批间稳定,可特异性促内皮细胞增殖介导血管生成,适用于血管、肿瘤、组织工程、创面修复研究。" data-qmeta="description">

3522集团新网站

分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

A scalable two-step genome editing strategy for generating full-length gene-humanized mice at diverse genomic loci

Taguchi Jumpei, Kikuchi Mio, Jeon Hyojung, Shimizu Ryo, Mori Hideto, Ikawa Masahito, Yamada Yasuhiro, Sato Kei, Ikeda Terumasa, Yamazaki Satoshi, Ozawa Manabu

Journal:Nature Communications

IF:18.1

DOI:10.1038/s41467-025-67900-4

PMID:

Published:2026-01-14

research field:肿瘤学分子生物学药理学肝脏病学

Abstract

Full-length gene-humanized mice engineered by completely replacing mouse loci with human counterparts, including untranslated and regulatory regions, provide a robust in vivo platform for human gene function studies. However, reliably humanizing large genomic regions remains challenging due to limited DNA insert sizes, complex protocols, and specialized material requirements. This study introduces a streamlined approach that enables full-length gene humanization through two sequential CRISPR-assisted homologous recombination steps in embryonic stem cells. This method supports targeted knock-in of genomic fragments ( > 200 kbp) and is applicable across multiple mouse strains. Humanized alleles generated using the developed method recapitulate human-like splicing isoforms and organ-specific gene expression while restoring essential functions in hematopoiesis, spermatogenesis, and survival. Furthermore, disease-associated mutations can be engineered into humanized alleles to model human genetic disorders in vivo. This versatile platform enables the creation of physiologically relevant, fully gene-humanized mouse models for broad applications in biomedical research.

本文使用的Yeasen产品

购物车
客服
转染试用